Track the PNV share price and the full insider trade history of the company, a listed issuer based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Health Care sector, PNV has published 8 reports. Market capitalisation: €666.7m. The latest transaction was filed on 23 August 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. All data is accessible without an account.
8
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate PNV Buy (bullish), based on 8 analysts. Average price target: A$1.46.
Fundamental score
Ranked 13,664 of 29,063 companies
53.6
score / 100
Value
43
Quality
64
FCF yld1.3%
Earn yld1.1%
EV/EBITDA·
ROE8.4%
Gross mgn89%
Net mgn5.1%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
PNV es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XASX. Se enfoca en desarrollar soluciones innovadoras para mejorar la atención médica.